Breaking News

Biognosys Opens New Proteomics Facility in MA

Expansion facilitates access to select proteomics contract research organization (CRO) services for the company’s US biopharma customers.

Author Image

By: Charlie Sternberg

Associate Editor

Biognosys, an expert in next-generation proteomics solutions for drug discovery and development, has announced the operational readiness of its new proteomics facility in Massachusetts.   This US expansion facilitates access to select proteomics contract research organization (CRO) services for the company’s US biopharma customers. About the Facility The Massachusetts facility will initially focus on TrueDiscovery data-independent acquisition (DIA) discovery proteomics services that offer...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters